Genmab A/S (GMAB) Reports FY EPS of $15.37
Genmab A/S (NASDAQ: GMAB) reported FY EPS of $15.37. Revenue for the period came in at $3.72 billion.
For earnings history and earnings-related data on Genmab A/S (GMAB) click here.
Genmab A/S (NASDAQ: GMAB) reported FY EPS of $15.37. Revenue for the period came in at $3.72 billion.
For earnings history and earnings-related data on Genmab A/S (GMAB) click here.